163 results on '"Rieke, Damian"'
Search Results
2. Adressen
3. Tumor- und therapieassoziierte Notfälle
4. Supportive Therapie
5. How to Standardize Molecular Profiling Programs for Routine Patient Care
6. Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis
7. Tumour mutational burden and survival with molecularly matched therapy
8. Prognostic factors in surgically treated malignant salivary gland tumors
9. A community approach to the cancer-variant-interpretation bottleneck
10. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
11. Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
12. Therapie der bösartigen Speicheldrüsentumoren
13. Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis
14. Leveraging Large Language Models for Decision Support in Personalized Oncology
15. A vision: in silico clinical trials without patients
16. Supportive Therapien
17. Contributors
18. Community-driven development of a modified progression-free survival ratio for precision oncology
19. Molekulare Onkologie – wo stehen wir heute?
20. Tumor- und therapieassoziierte Notfälle
21. Supportive Therapie
22. Gynäkologische Tumoren
23. Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]
24. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC
25. Cancer Precision Medicine : Why More Is More and DNA Is Not Enough
26. Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma
27. Abstract 926: Genomics-based personalized oncology of advanced thymic epithelial tumors
28. Supplementary Figure S3 from Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
29. Supplementary Table S2 from Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
30. Supplemental Materials and Legend from Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
31. VIST - a Variant-Information Search Tool for precision oncology
32. Variant information systems for precision oncology
33. CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase
34. Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study
35. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC
36. Additional file 1 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
37. CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.
38. 2 - Supportive Therapien
39. Chapter 5 - A vision: in silico clinical trials without patients
40. Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation community
41. Annotation and initial evaluation of a large annotated German oncological corpus
42. A CD205-directed antibody drug conjugate – lymphoma precision oncology or sophisticated chemotherapy?
43. Abstract 3222: The Virtual Molecular Tumor Board of the Variant Interpretation for Cancer Consortium: A systematic gateway connecting cancer genome interpretation and progress in genomic knowledgebases in cancer
44. Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC
45. Comparison of the clinical interpretation of high-dimensional molecular data by two molecular tumor boards.
46. Association of a STK11/KEAP1-mutation gene expression signature in lung adenocarcinoma with immune desertion in squamous cell carcinomas and mediation by NFE2L2 deregulation.
47. Support of a molecular tumour board by an evidence-based decision management system for precision oncology
48. Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes
49. Comparative Analysis of Public Knowledge Bases for Precision Oncology
50. 4.-8. März 2019
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.